IDiyas

For the Inventor, By the Inventor

Yongin-si, South Korea

Kyung Eun Kim

USPTO Granted Patents = 14 

 

Average Co-Inventor Count = 4.8

ph-index = 4

Forward Citations = 36(Granted Patents)


Company Filing History:

goldMedal14 out of 131,214 
 
Samsung Electronics Co., Ltd.
 patents
silverMedal1 out of 2,607 
 
Korea Advanced Institute of Science and Technology
 patents
where one patent can have more than one assignee

Years Active: 2015-2021

Loading Chart...
Loading Chart...
14 patents (USPTO):Explore Patents
1. 11174309 - Anti-ANG2 antibody (2021-11-16),
2. 11155627 - Anti-c-Met/anti-Ang2 bispecific antibody (2021-10-26),
3. 10246511 - Fusion polypeptide capable of binding simultaneously to VEGF-C and VEGF-D (2019-04-02),
4. 10047154 - Angiopoietin-2 specific antibodies and uses thereof (2018-08-14),
5. 9902767 - Method of blocking vascular leakage using an anti-ANG2 antibody (2018-02-27),
6. 9828422 - Anti-Ang2 antibody (2017-11-28),
7. 9725513 - Fusion polypeptide inhibiting VEGF-C, VEGF-D and/or angiopoietin-2, and use thereof (2017-08-08),
8. 9637541 - Anti-C-Met/anti-Ang2 bispecific antibody (2017-05-02),
9. 9580497 - Antibody specifically binding to ANG2 and use thereof (2017-02-28),
10. 9562093 - Antibodies or antigen-binding fragments thereof specifically binding to VEGF-C and use thereof (2017-02-07),
11. 9556275 - Combination therapy using anti-C-met antibody and anti-ang-2 antibody (2017-01-31),
12. 9527910 - Ang-2 specific antibodies and uses thereof (2016-12-27),
13. 9505841 - Use of an anti-Ang2 antibody (2016-11-29),
14. 9193768 - Peptide for inhibition of binding between angiopoietin-2 and integrin and use thereof (2015-11-24),

Title: Innovations of Kyung Eun Kim

Introduction

Kyung Eun Kim is a prominent inventor based in Yongin-si, South Korea. She has made significant contributions to the field of biotechnology, particularly in the development of innovative antibodies. With a total of 14 patents to her name, her work has the potential to impact cancer treatment and other medical applications.

Latest Patents

Among her latest patents is the Anti-ANG2 antibody, which specifically binds to the angiogenesis-inducing factor Angiopoietin-2 (Ang2) and complexes with a Tie2 receptor and Ang2. This invention has implications for understanding and potentially treating diseases related to angiogenesis. Another notable patent is the Anti-c-Met/anti-Ang2 bispecific antibody, which includes a composition for preventing and/or treating cancer by administering this bispecific antibody to patients.

Career Highlights

Kyung Eun Kim has worked with leading organizations such as Samsung Electronics Co., Ltd. and the Korea Advanced Institute of Science and Technology. Her experience in these institutions has allowed her to develop her expertise in biotechnology and contribute to groundbreaking research.

Collaborations

She has collaborated with notable colleagues, including Sang Yeul Han and Hyung-Chan Kim, to advance her research and innovations in the field.

Conclusion

Kyung Eun Kim's contributions to biotechnology through her patents and collaborations highlight her role as a leading inventor in her field. Her work continues to pave the way for advancements in medical treatments and therapies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…